scorecardresearch
Add as a preferred source on Google
Wednesday, November 5, 2025
TopicJohnson and Johnson

Topic: Johnson and Johnson

Johnson & Johnson stops selling baby powder in US, Canada after multiple lawsuits

The healthcare giant has faced lawsuits accusing it of hiding the cancer risks tied its talc-based version of baby powder since 2014.

Study finds baby powder not likely a risk for ovarian cancer

The US-govt-sponsored study may help Johnson & Johnson's fight against 17,000 lawsuits contending that talc-based personal hygiene products cause ovarian cancer in women.

J&J says no asbestos found in baby powder, disputing FDA test

The company suggested that contamination of a lab, which it recreated in several of its own third-party tests, could have caused the FDA’s positive result.

India to re-test Johnson & Johnson baby powder samples, after firm recalls batch in US

Last week, US Food and Drug Administration issued an alert that a particular lot of J&J’s baby powder had tested positive for asbestos — a carcinogen.

Johnson & Johnson recalls baby powder batch in US after tests find cancer-causing asbestos

J&J has been under scanner for long, but this is the first time FDA has announced a finding of asbestos. Recent lab tests in India had found the product fit.

Govt says J&J baby shampoo safe, months after it was flagged for cancer-causing substance

The Rajasthan FDA in March had claimed that two batches of J&J baby shampoo were found contaminated with formaldehyde, a carcinogen.

Johnson & Johnson directed to pay Rs 25 lakh each to 67 patients for faulty hip implants

The Delhi High Court said it hadn't examined the controversy so this payment won't limit patients from seeking further compensation.

Boeing’s 737 Max defence is a textbook mess

With Boeing not having informed pilots about the new automated feature, its main defence in the 2 crashes that killed 346 people boils down to quibbling about the meaning of the term safety feature.

After J&J implant row, govt plans to hire 750 officers to regulate medical devices

Plan is to hire these officers, who will exclusively regulate sale of medical devices such as coronary stents & hip implants, through a written exam conducted by UPSC.

Delhi HC junks Johnson & Johnson plea for stay on Rs 74 lakh payout for faulty hip implant

The Delhi High Court order on Johnson & Johnson's stay plea comes days before the Centre's deadline for the payout — 10 April — expires.

On Camera

Indians have a complicated relationship with Zohran Mamdani

Mamdani’s politics feels unusual compared to India’s current climate. He unapologetically foregrounds Muslim identity at a time when doing so in India invites scrutiny.

What does NCLAT order mean for data-sharing ban, penalty imposed by CCI on Meta & WhatsApp

On 4 November 2025, NCLAT bench, comprising Chairperson Justice Ashok Bhushan and Member Arun Baroka, noted that WhatsApp and Meta are distinct legal entities.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.